Publications by authors named "Frederic Villain"

Claim this Profile
G
Glycopyrronium 320 μg/mL in children and adolescents with severe sialorrhoea and neurodisabilities: An open-label study extension of the SALIVA trial.
Pierre Fayoux, Mickael Dinomais, Helen Shaw, Frédéric Villain, Déborah Schwartz

Dev Med Child Neurol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycopyrronium 320 μg/mL in children and adolescents with severe sialorrhoea and neurodisabilities: A randomized, double-blind, placebo-controlled trial.
Pierre Fayoux, Mickael Dinomais, Helen Shaw, Frédéric Villain, Déborah Schwartz

Dev Med Child Neurol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomised, double-blind, placebo-controlled trial of glycopyrronium in children and adolescents with severe sialorrhoea and neurodisabilities: protocol of the SALIVA trial.
Pierre Fayoux, Mickael Dinomais, Helen Shaw, Nick Probert, Frédéric Villain

BMJ Paediatr Open· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis